Little Bone Earring

Bold + Marcio Krakhecke collab earring.

 

Non-oxidizable metal earring.

 

NOTE: the product corresponds to a unit for one ear and not the earring pair.

Little Bone Earring

R$69.00 Regular Price
R$41.40Sale Price

    Perguntas Frequentes

    About the Study

    Why is this study being conducted?


    We would like to learn more about what is important to those diagnosed with a myelodysplastic disease to improve how drug developers measure quality of life and the patient experience when using new products. The purpose of this research study will be to explore your personal values, goals, needs, and symptomatic experiences in the treatment of your condition, specifically in regards quality of life; in efforts to align an existing quality of life measurement instruments to capture change. To do this, we are interested in learning more about you, your concerns, symptomatic burden, and your experiences with a myelodysplastic disease. We would like to know the different ways in which myelodysplastic disease affects your daily life, quality of life, and what contributing factors influenced your treatment decisions.




    Why should you take part in this study?


    Your participation in this research study is entirely voluntary. Participants may derive no direct benefit from participating in this research study, however, they will be contributing efforts to improve future assessments of quality of life in clinical trials and may feel that they have contributed to science as a result of their participation. Thus, the potential benefit is that knowledge gained from this study will optimize the role patients have in the development of new treatments and clinical decision making. The information will ultimately help researchers to better identify the suitability of existing patient-reported outcome measurement (PROM) instruments for use with High-Risk Myelodysplastic disease (MDS) and Acute Myelogenous Leukemia (AML) in the clinical research setting. The guidance provided from this study, regardless of phase two results, will enhance MDS and AML patient-reported outcome (PRO) trial data, which will lead to a range of benefits for patients and society. Direct results from this study may lead to more effective PRO implementation in MDS/AML research, widespread efforts to improve PRO compliance and outcome reporting, and an improved understanding of how emerging treatments are affecting the quality of life of patients diagnosed with these diseases. The qualitative data generated from patient interviews will provide the empirical basis needed to identify individual concepts within the larger HRQoL domains, creating a conceptual model of patient experiences. Establishing content validity between a patient population and an existing instrument may strengthen the body of evidence regarding MDS/AML treatment impact on quality of life. The proposed study will, in theory, generate a comprehensive account of patient experiences, highlighting the unfortunate spectrum of symptoms and quality of life impacts MDS and AML patients go through.
    If you decide not to participate, there will be no penalty to you, and you will not lose any benefits to which you are otherwise entitled. You can decide to withdraw your consent and stop participating in the research at any time, without any penalty.




    Who qualifies for this study?


    Participants with High-risk MDS and AML living within the United States will be recruited for participation in qualitative remote-based interviews. Potential participants will be screened prior to enrollment to determine eligibility, presents of potential confounding variables (such as demographics, depression, length of disease, relapse status, etc.). Participants must be over the age of 18 and currently be under the care of a licensed Oncologist/Hematologist for the treatment of their disease. Participants must be willing to speak freely about their disease, quality of life, preferences regarding treatment, and health-related concerns.




    What does this study entail?


    If you accept the invitation to participate in this research, you will be asked to take part in a non-formal video interview with a researcher to discuss your quality of life and your experiences. You will be able to participant in the study 100% remotely. No in-person visits will be required. The video interview will require you to consider your well-being, morbidity, mortality, treatment goals, life impact, and your experiences with your current or past treatment. This interview will be scheduled at your convenience, using a video conferencing platform that is mutually compatible between you and the researcher and will last approximately one (1) hour. Following your interview (no later than five weeks), you will be provided with a survey for you to rank items related to your health that you personally determine to be important to be measured as part of your care. This survey is estimated to take approximately 30 minutes to complete. The duration of your total involvement in this research is estimated to last ten (10) weeks from recruitment to completion of the follow-up survey, and all procedures will be conducted remotely.




    What happens if I want to participate?


    If you accept the invitation to participate in this research, you will be asked to take part in a non-formal video interview with a researcher to discuss your quality of life and your experiences. The video interview will require you to consider your well-being, morbidity, mortality, treatment goals, life impact, and your experiences with your current or past treatment. This interview will be scheduled at your convenience, using a video conferencing platform that is mutually compatible between you and the researcher and will last approximately one (1) hour. Following your interview (no later than five weeks), you will be provided with a survey for you to rank items related to your health that you personally determine to be important to be measured as part of your care. This survey is estimated to take approximately 30 minutes to complete. The duration of your total involvement in this research is estimated to last ten (10) weeks from recruitment to completion of the follow-up survey, and all procedures will be conducted remotely.




    How much time will it take?


    The interview will last approximately one (1) hour. The follow-up survey is estimated to take approximately 30 minutes to complete.
    The duration of your total involvement in this research is estimated to last ten (10) weeks from recruitment to completion of the follow-up survey, and all procedures will be conducted remotely.




    Will I be compensated for my time?


    You will be compensated for you time and efforts in this study in the form of an Amazon digital gift card. Payments will be made directly to your email after each study procedure. A $15 gift card will be provided after completion of the video interview, and a $10 gift card will be provided after completion of the web-based survey, totaling a compensation of $25 if you complete all study procedures.




    Who can I contact for more information?


    This research study is being conducted as part of a doctoral dissertation through the George Washington University's School of Medicine & Health Sciences Program.
    Principal Investigator: Mary A. Corcoran, Ph.D.
    Student Investigator: Anthony J. Messina, Ph.D. (c).

    If you have questions about this study, potential participation, or would like to speak with the research team, you can complete the form below or directly email Anthony Messina at: ajmessina@gwu.edu





    Did you like the model but couldn't find it in stock at the moment?

    Inform us! If it returns, you will be the first to know.

    I wanna, but it's not available!

    • Instagram - BOLDSTRAP

    Razão Social: Bold Strap Moda e Confecções LTDA 

    CNPJ: 33.076.887/0001-50 

    © 2018 BOLD STRAP

    Rua Norma Pieruccini Gianotti, 146, Sala 06

    Cep: 01137-010  | São Paulo - SP, Brasil